R&D tax relief can provide valuable financial support to life sciences and medtech businesses, but navigating the rules and understanding how they apply to complex research and development activities can be challenging. With significant changes to the R&D tax relief regime in recent years and continued scrutiny of claims, understanding both the opportunities and the requirements has never been more important.
From early-stage biotech companies to established medtech innovators, businesses across the sector face unique considerations when preparing R&D tax relief claims. Long development timelines, clinical research, regulatory requirements, collaborative projects and specialist subcontracting arrangements can all add complexity to the claims process.
As a life science business looking ahead to 2027, now is an important time to review your approach to R&D tax relief, understand the implications of the current landscape and ensure you are well positioned for future claims. In this practical, sector-focused webinar, specialist R&D tax relief consultancy LimestoneGrey will explore the key challenges, considerations, and opportunities for research-led businesses, including:
•    Navigating the R&D tax relief schemes: Understanding the merged R&D scheme and Enhanced R&D Intensive Support (ERIS), eligibility requirements, and the potential financial and compliance implications of claiming under the wrong relief.
•    Understanding the impact of collaborative research: Exploring how research partnerships, CROs and subcontracted R&D activities can influence claim eligibility and entitlement.
•    Exploring changes to the rules on funded R&D: Understanding how the revised rules on funded projects affect your future claims.
•    Building robust supporting evidence: The importance of effective record keeping throughout the R&D lifecycle, particularly for complex, multi-year research projects.
•    Preparing a compliant and well-supported claim: Understanding HMRC's Additional Information Form (AIF), technical documentation requirements, and the importance of presenting a clear, defensible claim.
•    Recognising key deadlines and notification requirements: Avoiding common procedural pitfalls, particularly for businesses claiming for the first time or returning to R&D tax relief after a period of not claiming.

Who should attend?
This webinar is designed for founders, CEOs, CFOs, finance professionals, scientific leaders and R&D managers working across the life sciences, biotechnology, pharmaceutical and medtech sectors.
Whether you're an early-stage business considering R&D tax relief for the first time, a growing company managing increasingly complex research arrangements, or an established organisation looking to strengthen its existing claims process, the session will provide practical, sector-specific insights to help you approach R&D tax relief with greater confidence in 2027.

Complimentary R&D Tax Relief Health Check
Attendees will also have the opportunity to access LimestoneGrey's complimentary R&D tax relief health check. This provides an opportunity to discuss your business's individual circumstances, review your current approach to claiming R&D tax relief and identify potential areas for improvement.

Meet the Speaker – Matthew Jones, LimestoneGrey
Matthew Jones is the Managing Director of LimestoneGrey, a regulated consultancy specialising in R&D tax relief. A dual-qualified Chartered Accountant and Chartered Tax Adviser, Matthew brings a wealth of technical expertise and experience supporting innovative businesses across the life sciences, biotechnology and medtech sectors. He understands the unique challenges faced by research-led companies in this space and the importance of navigating R&D tax relief with care and confidence.
Passionate about making complex legislation accessible, Matthew takes a practical and educational approach, helping businesses understand their R&D tax relief opportunities, navigate HMRC requirements and build robust, compliant claims.

This webinar is:
•    Free for employees of One Nucleus member organisations;
•    £75 + VAT for Non Members.